Ibio Inc - ESG Rating & Company Profile powered by AI
This article includes a Q&A section for Ibio Inc. This Sustainability score for Ibio Inc indicates its transparency towards the UN Sustainable Development Goals. The analysis of Ibio Inc is assembled by All Street Sevva using proprietary AI.
Ibio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 8.0, social score of 4.8 and governance score of 8.0.
6.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 290 | Qiagen NV | 7.0 | High |
| 290 | WuXi AppTec Co Ltd | 7.0 | High |
| 294 | Ibio Inc | 6.9 | High |
| 294 | Cabaletta Bio Inc | 6.9 | High |
| 294 | Bicycle Therapeutics PLC | 6.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ibio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ibio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ibio Inc report the average age of the workforce?
Sign up for free to unlockDoes Ibio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ibio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ibio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ibio Inc offer flexible work?
Sign up for free to unlockDoes Ibio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ibio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ibio Inc conduct supply chain audits?
Sign up for free to unlockDoes Ibio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ibio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ibio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ibio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ibio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ibio Inc disclose water use targets?
Sign up for free to unlockDoes Ibio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ibio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ibio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ibio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ibio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ibio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ibio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ibio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ibio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ibio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ibio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ibio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ibio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ibio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ibio Inc disclose its waste policy?
Sign up for free to unlockDoes Ibio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ibio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ibio Inc disclose energy use targets?
Sign up for free to unlockDoes Ibio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ibio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ibio Inc
These potential risks are based on the size, segment and geographies of the company.
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates through two segments, Biopharmaceuticals and Bioprocessing. Its lead anti-fibrotic candidate is IBIO-100 for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-202 , which is the Nucleocapsid (N) protein for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties; and offers a range of process development, manufacturing, and bio analytic services. iBio, Inc. has a license agreement with University of Pittsburgh; a non-exclusive agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with RubrYc. The company was incorporated in 2008 and is headquartered in Bryan, Texas.